Abstract
In this Decade in Review article, I highlight the top 10 advances in heart failure (HF) over the past decade, including new pharmacological therapies and expanded indications for devices in HF with reduced ejection fraction. The poor progress in acute HF and HF with preserved ejection fraction is emphasised. Biomarkers and devices that help prevent, detect, and guide treatment represent the future of HF management.
| Original language | English |
|---|---|
| Pages (from-to) | 631 - 632 |
| Number of pages | 2 |
| Journal | Nature Reviews Cardiology |
| Volume | 11 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2014 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver